Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial. (Lancet, 2014)

(untitled) - Haynes, R; Harden, P; Judge, P; Blackwell, L; Emberson, J; Landray, M; Baigent, C; Friend, P